NO931709D0 - Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon - Google Patents

Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Info

Publication number
NO931709D0
NO931709D0 NO931709A NO931709A NO931709D0 NO 931709 D0 NO931709 D0 NO 931709D0 NO 931709 A NO931709 A NO 931709A NO 931709 A NO931709 A NO 931709A NO 931709 D0 NO931709 D0 NO 931709D0
Authority
NO
Norway
Prior art keywords
enzymers
self
nucleic acid
acid amplification
sequence replication
Prior art date
Application number
NO931709A
Other languages
English (en)
Other versions
NO931709L (no
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of NO931709D0 publication Critical patent/NO931709D0/no
Publication of NO931709L publication Critical patent/NO931709L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO93931709A 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon NO931709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13
PCT/US1991/008488 WO1992008800A1 (en) 1990-11-13 1991-11-13 Nucleic acid amplification by two-enzyme, self-sustained sequence replication

Publications (2)

Publication Number Publication Date
NO931709D0 true NO931709D0 (no) 1993-05-11
NO931709L NO931709L (no) 1993-07-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931709A NO931709L (no) 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Country Status (13)

Country Link
EP (1) EP0572417A4 (no)
JP (1) JPH06502767A (no)
AU (1) AU9131591A (no)
CA (1) CA2096013A1 (no)
FI (1) FI932144A (no)
HU (1) HUT69772A (no)
IE (1) IE913930A1 (no)
IL (1) IL100040A (no)
NO (1) NO931709L (no)
NZ (1) NZ240574A (no)
PT (1) PT99500A (no)
WO (1) WO1992008800A1 (no)
ZA (1) ZA918965B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011507A2 (en) * 1992-11-19 1994-05-26 Gingeras Thomas R Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna
EP0682121B1 (en) * 1993-12-01 2002-08-28 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (ja) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (ja) * 1999-07-16 2001-02-06 Shimadzu Corp Ｒｎａ増幅法
WO2002012263A1 (en) 2000-08-03 2002-02-14 Roche Diagnostics Gmbh Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
EP1466018B2 (en) 2002-01-08 2015-08-12 Roche Diagnostics GmbH Use of silica material in an amplification reaction
US7122314B2 (en) 2002-01-30 2006-10-17 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
ES2294462T5 (es) 2003-01-29 2015-05-06 Epigenomics Ag Método mejorado para el tratamiento de bisulfito
JP2004357502A (ja) * 2003-05-30 2004-12-24 Olympus Corp 核酸分子を使用した情報処理方法
US20090232771A1 (en) 2004-07-13 2009-09-17 Takeda Pharmaceutical Company Limited Method of controlling cell functions
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
JP5777340B2 (ja) 2007-08-06 2015-09-09 オリオン ゲノミクス エルエルシー Ｉｇｆ２遺伝子の対立遺伝子特異的な発現を判定するための一塩基多型ならびに新規および公知の多型の組み合わせ
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
US20100330097A1 (en) 2007-11-01 2010-12-30 Hageman Gregory S Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
JP5748672B2 (ja) 2009-02-11 2015-07-15 オリオン ゲノミクス エルエルシー Ｉｇｆ２の対立遺伝子特異的な発現を判定するための多型の組み合わせ
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CA2801468C (en) 2010-06-04 2018-09-04 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
US9458484B2 (en) 2010-10-22 2016-10-04 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
MX2014002311A (es) 2011-08-31 2014-08-26 Hoffmann La Roche Capacidad de respuesta a inhibidores de angiogenesis.
CN103946395A (zh) 2011-08-31 2014-07-23 霍夫曼-拉罗奇有限公司 用于预测与抗血管发生疗法有关的高血压的风险的方法
AU2012312515A1 (en) 2011-09-19 2014-03-13 Genentech, Inc. Combination treatments comprising c-met antagonists and B-raf antagonists
ES2729554T3 (es) 2011-10-21 2019-11-04 Chronix Biomedical Biomarcadores de ácidos nucleicos en circulación asociados al cáncer colorrectal
MX2014006186A (es) 2011-11-23 2014-07-14 Hoffmann La Roche Capacidad de respuesta a los inhibidores de la angiogenesis.
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
SI3004388T2 (sl) 2013-05-29 2023-11-30 Chronix Biomedical Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov
CN106459993A (zh) 2014-03-31 2017-02-22 德彪药业国际股份公司 Fgfr融合体
US20160168640A1 (en) 2014-11-10 2016-06-16 Genentech, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
ES2961374T3 (es) 2015-04-24 2024-03-11 Atila Biosystems Incorporated Amplificación con cebadores de composición de nucleótidos limitada
EP3385395B9 (en) 2015-08-17 2020-05-20 Kura Oncology, Inc. Methods of treating cancer patients with farnesyl transferase inhibitors
WO2017184968A1 (en) 2016-04-22 2017-10-26 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
WO2018085518A2 (en) 2016-11-03 2018-05-11 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2018225566B2 (en) 2017-02-21 2019-11-07 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3071854A1 (en) 2017-08-07 2019-02-14 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3226165A1 (en) 2018-02-09 2019-08-15 Genentech, Inc. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
CN113286591A (zh) 2018-11-01 2021-08-20 库拉肿瘤学公司 用法尼基转移酶抑制剂治疗癌症的方法
WO2020180663A1 (en) 2019-03-01 2020-09-10 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
EP3946338A1 (en) 2019-03-29 2022-02-09 Kura Oncology, Inc. Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
US20220168296A1 (en) 2019-04-01 2022-06-02 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
CN115315527A (zh) 2020-03-13 2022-11-08 免疫医疗有限公司 用于治疗il33中存在风险等位基因的受试者的治疗方法
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
WO1990006995A1 (en) * 1988-12-16 1990-06-28 Siska Diagnostics, Inc. Self-sustained sequence replication system
DE69034177T2 (de) * 1989-07-11 2005-10-27 Gen-Probe Inc., San Diego Verfahren zur Amplifikation von Nukleinsäuresequenzen

Also Published As

Publication number Publication date
EP0572417A1 (en) 1993-12-08
FI932144A0 (fi) 1993-05-12
NO931709L (no) 1993-07-12
NZ240574A (en) 1994-10-26
EP0572417A4 (en) 1994-11-23
WO1992008800A1 (en) 1992-05-29
HUT69772A (en) 1995-09-28
IL100040A (en) 1995-12-31
IL100040A0 (en) 1992-08-18
ZA918965B (en) 1992-08-26
PT99500A (pt) 1992-10-30
IE913930A1 (en) 1992-06-17
FI932144A (fi) 1993-05-12
AU9131591A (en) 1992-06-11
CA2096013A1 (en) 1992-05-14
JPH06502767A (ja) 1994-03-31
HU9301369D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
NO931709D0 (no) Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon
FI924188A0 (fi) Platsspecifik spjaelkning av en enkelstraengad dna.
DE3884094D1 (de) Kinderwagen.
FI884966A0 (fi) N-substituerade derivat av 1-desoxinojirimycin och desoximannonojirimycin, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
NO904634D0 (no) Amplifikasjon av nukleinsyre ved anvendelse av ligerbare,haarnaalsprobe og transkripsjon.
FI880428A0 (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
DE3879627D1 (de) Huellkurvenverstaerker.
FI885735A (fi) System foer godstransport, vilka aer transformerbara till jaernvaegsfordon och med systemet anvaendbara boggier.
FI872965A0 (fi) Foerfarande och anordning foer kapning av papper, isynnerhet foerperforerat papper.
FI872147A (fi) Fiskfoder, foerfarande foer framstaellning av detsamma och utfodringsfoerfarande.
FI881434A (fi) Foerfarande foer framstaellning av imidazopyridinderivat vilka aer terapeutiskt anvaendbara.
FI895593A (fi) Anordning i synnerhet foer behandling av kraemer och pastor.
FI882634A (fi) Pressvals, vars boejning aer instaellbar.
FI885707A (fi) Foerfarande foer frihaollning av genomstroemningskanalen till en staonggjutmaskins glidlucka.
DE3850923D1 (de) Operationsverstärkerstufen.
NO882048D0 (no) Stillas.
FI871990A0 (fi) Anordning foer distribuering av ved till matningsschakt foer slipmaskiner.
FI881268A0 (fi) Hybridserpiner och dessa kodande dna:n.
DE69010711T2 (de) Differenzverstärker.
FI881848A0 (fi) Av med varandra foerbundna delar sammansatt slang, speciellt korvskinnn av konstmaterial.
FI873317A0 (fi) Foerfarande och anordning foer bestrykning av laongstraeckta staolstycken, isynnerhet betongstaol och staolprofiler.
FI874598A0 (fi) Anordning foer samling av baer fraon buskar.
FI902834A0 (fi) Produktion av filterkakor och liknande.
FI872588A0 (fi) Foerfarande, saendare och mottagare foer oeverfoerande av digitalisk tillaeggsinformation.
ATE84527T1 (de) Pyrimidinderivate.